Popular
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CEFrontline Insights: Emerging Therapeutic Strategies in HNSCC
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
- CME/CE In-Person & Virtual Event
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
March 12, 2026
Orlando, Florida Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
CME/CENavigating Treatment Sequencing After Frontline Treatment Failure in CLL
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
CME/CEAdvancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
Programs
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CEFrontline Insights: Emerging Therapeutic Strategies in HNSCC
From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
CME/CEFrom Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
- CME/CE In-Person & Virtual Event
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
March 12, 2026
Orlando, Florida - CME/CE In-Person & Virtual Event
Beyond IOP: Integrating Ocular Surface Resilience into Glaucoma Management
March 13, 2026
Orlando, Florida Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
Clinical Practice
Postpartum Depression: A Common Yet Overlooked Condition
Medical Industry FeaturePostpartum Depression: A Common Yet Overlooked Condition
Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
MinuteCE®Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Doctors Lounge
"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
The Convergence"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm
Death by Planet? Strange Diagnoses from 1632 London’s Medical Records
Rub Some Dirt In ItDeath by Planet? Strange Diagnoses from 1632 London’s Medical Records
Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Clinician's RoundtableDisparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
The ConvergenceNext-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's RoundtableArtificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
On the Frontlines of OsteoporosisDisparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
CME
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
CME/CEMissing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
Inside the IgAN Clinic: Shared Decision-Making Into Practice
CME/CEInside the IgAN Clinic: Shared Decision-Making Into Practice
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CEGDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
Industry Feature
Early Referral in PMR Management and the Impact on Outcomes
Medical Industry FeatureEarly Referral in PMR Management and the Impact on Outcomes
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Medical Industry FeatureAmyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Targeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Medical Industry FeatureTargeting Neutrophilic Inflammation in Bronchiectasis: An Emerging Approach
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk